Instil Bio, Inc. (TIL)
7.58
-0.08
(-1.04%)
USD |
NASDAQ |
Sep 04, 16:00
7.58
0.00 (0.00%)
After-Hours: 20:00
Instil Bio Total Assets (Quarterly) : 197.71M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 197.71M |
| March 31, 2026 | 200.43M |
| December 31, 2025 | 205.66M |
| September 30, 2025 | 211.77M |
| June 30, 2025 | 230.99M |
| March 31, 2025 | 237.45M |
| December 31, 2024 | 264.76M |
| September 30, 2024 | 272.56M |
| June 30, 2024 | 294.32M |
| March 31, 2024 | 306.30M |
| December 31, 2023 | 325.63M |
| September 30, 2023 | 340.27M |
| Date | Value |
|---|---|
| June 30, 2023 | 408.31M |
| March 31, 2023 | 427.17M |
| December 31, 2022 | 482.13M |
| September 30, 2022 | 532.74M |
| June 30, 2022 | 568.54M |
| March 31, 2022 | 564.94M |
| December 31, 2021 | 609.98M |
| September 30, 2021 | 647.40M |
| June 30, 2021 | 672.67M |
| March 31, 2021 | 696.14M |
| December 31, 2020 | 319.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 90.33M |
| Shareholders Equity (Quarterly) | 107.38M |
| Debt to Equity Ratio | 0.8141 |
| Current Ratio | 21.67 |
| Net Debt Paydown Yield | -0.29% |